These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 8729368
1. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications]. Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP. Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368 [Abstract] [Full Text] [Related]
2. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents]. Le Davay M, Victor J, Dupuis JM, Merheb M, Tran P, Tadeï A. Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416 [Abstract] [Full Text] [Related]
3. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia]. Pisapia A, Bine-Scheck F, Schenowitz A, Domerego JJ, Maraud L, Canler A, Labban N, Viart R, Aubry P, Beruben E. Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916 [Abstract] [Full Text] [Related]
4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F. Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [Abstract] [Full Text] [Related]
5. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?]. Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P, Louis P, Danchin N. Arch Mal Coeur Vaiss; 1997 Jul; 90(7):961-6. PubMed ID: 9339257 [Abstract] [Full Text] [Related]
6. [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis]. Aouate P, Elbaz N, Klug D, Lacotte J, Raguin D, Frank R, Lelouche D, Dubois-Randé JL, Tonet J, Fontaine G. Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1181-7. PubMed ID: 12611038 [Abstract] [Full Text] [Related]
7. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356 [Abstract] [Full Text] [Related]
8. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia? Wiesfeld AC, Ansink JM, van Veldhuisen DJ, van Gelder IC. Int J Cardiol; 2006 Feb 08; 107(1):140-1. PubMed ID: 15990183 [No Abstract] [Full Text] [Related]
9. [Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers?]. Brembilla-Perrot B, Houriez P, Claudon O, Yassine M, Suty-Selton C, Vancon AC, Abo el Makarem Y, Makarem E, Courtelour JM. Ann Cardiol Angeiol (Paris); 2000 Dec 08; 49(8):439-42; discussion 442-3. PubMed ID: 12555430 [Abstract] [Full Text] [Related]
10. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. Jastrzebski M. Kardiol Pol; 2008 Nov 08; 66(11):1221-4; discussion 1225. PubMed ID: 19105102 [Abstract] [Full Text] [Related]
11. [Persistent atrial flutter induced by propafenone (Rytmonorm)]. Fazekas T, Kiss J, Pap I, Rudas L. Orv Hetil; 1994 Aug 14; 135(33):1819-22. PubMed ID: 8072758 [Abstract] [Full Text] [Related]
12. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]. Rienstra M, Wiesfeld AC, van Veldhuisen DJ, van Gelder IC. Ned Tijdschr Geneeskd; 2006 May 06; 150(18):1027-31. PubMed ID: 16715868 [Abstract] [Full Text] [Related]
13. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B. Arch Mal Coeur Vaiss; 1984 Nov 06; 77(12):1370-82. PubMed ID: 6439161 [Abstract] [Full Text] [Related]
14. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway]. Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF. Ann Cardiol Angeiol (Paris); 1994 Apr 06; 43(4):194-203. PubMed ID: 8024234 [Abstract] [Full Text] [Related]
15. Proarrhythmic effects of class Ic drugs. Moroe K, Annoura M, Matsuo K, Yamanouchi Y, Kumagai K, Arakawa K. Clin Ther; 1993 Apr 06; 15(3):559-66. PubMed ID: 8364947 [Abstract] [Full Text] [Related]
16. [Problems with anti-arrhythmia therapy in atrial fibrillation]. Breithardt G, Kottkamp H, Haverkamp W, Hindricks G, Fetsch T, Borggrefe M. Z Kardiol; 1994 Apr 06; 83 Suppl 5():63-9. PubMed ID: 7846947 [Abstract] [Full Text] [Related]
17. [Wide QRS complex tachycardia: an old and new problem]. Oreto G, Luzza F, Satullo G, Donato A, Carbone V, Calabrò MP. G Ital Cardiol (Rome); 2009 Sep 06; 10(9):580-95. PubMed ID: 19891250 [Abstract] [Full Text] [Related]
18. [Catheter ablation in supraventricular tachycardia]. Pitschner HF, Neuzner J. Z Kardiol; 1996 Sep 06; 85 Suppl 6():45-60. PubMed ID: 9064982 [Abstract] [Full Text] [Related]
19. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ. Eur Heart J; 1995 Dec 06; 16(12):1930-5. PubMed ID: 8682029 [Abstract] [Full Text] [Related]
20. [Efficacy of propafenone in supraventricular arrhythmias]. Kauffmann R, Goich J, Parra C, Ayala A, Manzur F. Rev Med Chil; 1989 Apr 06; 117(4):401-5. PubMed ID: 2519393 [Abstract] [Full Text] [Related] Page: [Next] [New Search]